(61)MICROBIAL LIMIT TESTS《微生物限度测定》USP31

合集下载

微生物限度检查法-检验标准操作规程

微生物限度检查法-检验标准操作规程

——————————文件类别:技术标准 1/25文件名称微生物限度检查法(二部)检验标准操作规文件编号:09T-I636-01 起草人审核人批准人日期:日期:日期:颁发部门:质量管理部生效日期:分发部门:质量控制科1.目的:建立微生物限度检查法(二部)检验标准操作规程,并按规程进行检验,保证检验操作规范化。

2.依据:2.1.《中华人民共和国药典》2010年版二部。

3.范围:适用于所有用微生物限度检查法(二部)测定的供试品。

4.责任:检验员、质量控制科主任、质量管理部经理对本规程负责。

5.正文:5.1.简述:5.1.1. 微生物限度检查法系检查非规定灭菌制剂及其原料、辅料受微生物污染程度的方法。

检查项目包括细菌数、霉菌数、酵母菌数及控制菌检查。

5.1.2. 微生物限度检查应在环境洁净度10 000级下的局部洁净度100级的单向流空气区域内进行。

检验全过程必须严格遵守无菌操作,防止再污染。

防止污染的措施不得影响供试品中微生物的检出。

单向流空气区域、工作台面及环境应定期按《医药工业洁净室(区)悬浮粒子、浮游菌和沉降菌的测试方法》的现行国家标准进行洁净度验证。

5.1.3.供试品检查时,如果使用了表面活性剂、中和剂或灭活剂,应证明其有效性及对微生物无毒性。

5.1.4.除另有规定外,本检查法中细菌及控制菌培养温度为30~35℃,霉菌、酵母菌培养温度为23~28℃。

5.1.5.检验结果告以1g、1ml、10g、10ml或10cm2为单位报告,特殊品种可以最小包装单位报告。

5.2. 检验量。

5.2.1.检验量即一次试验所用的供试品量(g、ml 或cm2)。

5.2.2.除另有规定外,一般供试品的检验量为10 g或10ml;膜剂为100cm2;贵重药品、微量包装药品的检验量可以酌减。

要求检查沙门菌的供试品,其检验量应增加20g或20ml(其中10g或10ml用于阳性对照试验)。

5.2.3.检验时,应从2个以上最小包装单位中抽取供试品,膜剂还不得少于4片。

USP2022年版〈61〉非无菌产品微生物限度检查:微生物计数法-中文版

USP2022年版〈61〉非无菌产品微生物限度检查:微生物计数法-中文版

USP43 <61>非无菌产品微生物限度检查:微生物计数法介绍下文所述的试验将允许在有氧条件下生长的嗜温细菌和真菌的定量计数。

这些测试主要用于确定一种物质或制剂是否符合既定的微生物质量标准。

当用于此类目的时,应按以下的规定进行,包括要样品取样量,和解释判断如下所述结果。

本方法不适用于含有活微生物作为活性成分的产品。

可采用包括自动化方法在内的替代微生物学方法,前提是已经证明与药典方法等效。

一般程序在避免待检产品的受到外来微生物污染的条件下进行测定。

防止污染的措施必须确保不会影响待检产品中微生物的检出。

如果待检产品具有抗菌活性,则应尽可能将其去除或中和。

如果灭活剂用于此目的,必须证明其微生物有效性和无毒性。

如果表面活性物质用于样品制备,应确认其对微生物无毒性,并且与所用的任何灭活剂相容性。

计数方法按照说明,使用薄膜过滤法或平板计数法之一。

最可能数(MPN)法通常用于微生物计数准确度较差;但是,对于某些生物负荷非常低的产品,这可能是最合适的方法。

方法的选择是基于产品的性质和微生物限度标准等因素。

所选方法必须允许测试足够的样本量,以判断是否符合质量标准。

所选方法的适用性必须经确认。

生长促进试验、计数方法和阴性对照的适用性一般要求必须建立检测待测产品中微生物的能力。

如果引入了可能影响测试结果的测试性能或产品变化,则必须确认其适用性。

试验菌株的制备使用试验菌株的标准化稳定悬浮液或按如下所述进行制备。

采用适宜的菌种保藏技术,以确保用于接种的微生物的传代次数不超过5代。

如表1所述,分别培养每种细菌和真菌测试菌株。

霉孢子悬浮,可将0.05%的聚山梨醇酯80加入该缓冲液中。

悬浮液在2h之内使用,或存放在2~8℃条件下24h内使用。

作为制备并稀释黑曲霉或枯草杆菌营养细胞的新鲜悬浮液的替代方法,可制备稳定的孢子悬浮液,然后将适量的孢子悬浮液用于试验接种。

稳定的孢子悬浮液可在2~8℃下保存,保存期需经过时间验证。

微生物限度检查3篇

微生物限度检查3篇

微生物限度检查
第一篇:微生物限度检查概述
微生物限度检查(Microbial Limit Test,简称MLT)是对制剂中微生物数量进行测定的一种方法,是药品质量控制中非常重要的一环。

微生物在药品中存在可能会影响药品的质量、安全性以及疗效。

因此,微生物限度检查是保障药品质量和安全的关键环节之一。

微生物限度检查通常是针对某些指定的有害微生物,如
大肠杆菌、金黄色葡萄球菌等进行检测,通过这些微生物的限度常数,可以判断药品是否符合质量标准,进而保证药品的质量和安全性。

在进行微生物限度检查时,需要特别注意检测操作的洁
净度和严谨性,要求操作过程中不能够将无关微生物带入检测样品中,因此,检测过程中严格遵循操作规程和良好的实验技巧非常关键。

总的来说,微生物限度检查在药品质量控制中具有非常
重要的作用。

在检测操作过程中,不仅需要注意操作的洁净度,还需要准确判断检测数据的可靠性,确保所检测的微生物限度在规定范围内。

USP29(61)_微生物限度检查

USP29(61)_微生物限度检查

USP29-<61> 微生物限度检查<61> 微生物限度检查本章所提供的检测程序用于测定包括原料药及制剂在内的各种药品中需氧菌数量以及不含有指定的微生物。

如果已有充分的证据证明某种自动化的方法可以给出与本章所提供的方法等效的或更好的实验结果,可以用该方法替代本章所提供的方法。

在实验准备以及实施的过程中,应遵守无菌操作。

除另有规定外,本检查法中“孵育”是指将容器置于温度控制在30-35˚C的空气中24-48小时。

术语“生长”在此处是专用于表示存活的微生物的增殖。

预试验(验证试验)应有充分的证据证明在实验条件下检品本身对可能存在微生物的增殖无抑制作用,这在很大程度上决定了下述所规定的检查方法的结果有效性。

因此,应进行预试验,测定金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌以及沙门氏菌分别接种到稀释的检品中共同培养后的存活情况,以使检查标准化并作为随后试验的具体要求。

方法如下:接种1ml金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌以及沙门氏菌的24小时肉汤培养物(稀释度大于等于10-3)至最低稀释级样品供试液中(样品用pH 7.2磷酸盐缓冲液, 大豆-酪蛋白水解物琼脂培养基或乳糖液体培养基稀释),若微生物在相应的培养基中不能生长,则该部分试验无效,有必要按下述步骤对实验进行调整:通过(1),增加稀释剂的体积,供试品量保持不变,或(2)在稀释剂中加入足够量的灭活剂;或(3)适当地将(1)和(2)结合使接种物可以生长。

可在培养基中加入0.5%的大豆卵磷脂和4.0%的聚山梨酸酯-20以中和供试品中的所存在的抑菌成分。

或者用酪蛋白水解物-大豆卵磷脂-聚山梨酸酯-20-培养基按前述方法重复试验以确认对供试品中的保护剂或其他抗菌剂的中和作用。

若产品中含有抑菌成分,而该产品又是可溶的,可采用无菌检查项下产品的无菌检查法中的薄膜过滤法。

如果在加入灭活剂或大大增加稀释剂的体积后仍不能使上述培养物恢复存活,而且该产品不适合采用薄膜过滤法,可以作如下推断:所接种微生物的分离培养失败是由于该产品的抑菌活性。

微生物限度检查法-药典附录

微生物限度检查法-药典附录

微生物限度检查法微生物限度检查法(2005年版一部)附录ⅩⅢC. 微生物限度检查法微生物限度检查法系检查非规定灭菌制剂及其原料、辅料受微生物污染程度的方法。

检查项目包括细菌数、霉菌素、酵母菌数及控制菌检查。

微生物限度检查应在环境洁净度10000级下的局部洁净度100级的单向流空气区域内进行。

检验全过程必须严格遵守无菌操作,防止再污染。

单向流空气区域、工作台面及环境应定期按《医药工业洁净室(区)悬浮粒子、浮游菌和沉降菌的测试方法》的现行国家标准进行洁净度验证。

供试品检查时,如果使用了表面活性剂、中和剂或灭活剂,应证明其有效性及对微生物的生长和存活无影响。

除另有规定外,本检查法中细菌培养温度为30~35℃,霉菌、酵母菌培养温度为25~28℃,控制菌培养温度为36℃±1℃。

检验结果的报告以1g、1ml、10g、10ml或10cm2为单位报告。

检验量检验量即一次试验所用的供试品(g、ml 或cm2>)。

除另有规定外,一般供试品的检验量为10g或10ml;中药膜剂为50 cm2;贵重药品、微量包装药品的检验量可以酌减。

要求检查沙门菌的供试品,其检验应增加10g或10ml。

检验时,应从2个以上最小包装单位中抽取供试品,大蜜丸还不得少于4丸,膜剂还不得少于4片。

一般应随机抽取不少于检验用量(两个以上最小包装单位)的3倍量供试品。

供试液的制备根据供试品的理化特性与生物学特性,可采取适宜的方法制备供试液。

供试液制备若需用水浴加温时,温度不应超过45℃。

供试液从制备至加入检验用培养基,不得超过1小时。

除另有规定外,常用的供试液制备方法如下。

1.液体供试品取供试品10ml,加PH7.0无菌氯化钠-蛋白胨缓冲液至100ml,混匀,作为1:10的供试液。

油剂可加入适量的无菌聚山梨酯80使供试品分散均匀。

水溶性液体制剂也可用混合的供试品原液作为供试液。

2.固体、半固体或黏稠性供试品取供试品10g,加PH7.0无菌氯化钠-蛋白胨缓冲液至100ml,用匀浆仪或其他适宜的方法,混匀,作为1:10的供试液。

USP 通用章节目录

USP 通用章节目录

USP29-通用章节指导目录(附录)Guide to General Chapters 通用章节指导目录中此颜色并且带有“***”的为新增内容。

General Requirements for Test and Assays检查与含量分析的一般要求<1>INJECTIONS……2455注射剂<11>USP REFERENCE STANDARDS……2458USP对照品Apparatus for Test and Assays用于检查与含量分析的器具<16>AUTOMATED METHODS OF ANAL YSIS……2491自动化分析方法<21>THERMOMETERS……2497温度计<31>VOLUMETRIC APPARATUS……2497容量器具<41>WEIGHTS AND BALANCES……2499砝码与天平Microbiological Tests 微生物检查法<51>ANTIMICROBIAL EFFECTIVENESS TESTING……2499抗菌剂有效性检查法<55>BIOLOGICAL INDICATORS—RESISTANCE PERFORMANCE TESTS (2501)生物指示剂-耐药性实验<61>MICROBIAL LIMIT TESTS……2503微生物限度检查法<71>STERILITY TESTS……2508无菌检查法Biological tests and assays生物检查法与测定法<81>ANTIBIOTICS—MICROBIAL ASSAYS……2513抗生素-微生物测定<85>BACTERIAL ENDOTOXINS TEST……2521细菌内毒素检查法<87>BIOLOGICAL REACTIVITY TESTS, IN VITRO……2525体外的生物反应性检查法<88>BIOLOGICAL REACTIVITY TESTS, IN VIVO……2526体内的生物反应性检查法<91>CALCIUM PANTOTHENATE ASSAY……2530泛酸钙测定法<111>DESIGN AND ANAL YSIS OF BIOLOGICAL ASSAYS……2531 生物测定法的设计与分析<115>DEXPANTHENOL ASSAY……2543右泛醇(拟胆碱药)测定法<121>INSULIN ASSAYS……2544胰岛素测定法<141>PROTEIN—BIOLOGICAL ADEQUACY TEST……2546蛋白质-生物适应性试验<151>PYROGEN TEST……2546热原检查法<161>TRANSFUSION AND INFUSION ASSEMBLIES AND SIMILAR MEDICAL DEVICES (2547)输血输液用具以及相类似的医疗器械<171>VITAMIN B12 ACTIVITY ASSAY……2548维生素B12活性测定法Chemical Tests and assays化学实验与测定法<181>IDENTIFICATION—ORGANIC NITROGENOUS BASES (2549)鉴别-有机氮碱?<191>IDENTIFICATION TESTS—GENERAL……2550鉴别实验-通用<193>IDENTIFICATION—TETRACYCLINES……2551鉴别-四环素<197>SPECTROPHOTOMETRIC IDENTIFICATION TESTS......2552分光光度计鉴别实验<201>THIN-LAYER CHROMATOGRAPHIC IDENTIFICATION TEST.. (2553)薄层色谱鉴别实验Limit Test 限度检查法<206>ALUMINUM……2554铝<211>ARSENIC……2554砷<221>CHLORIDE AND SULFATE……2555氯和硫<223>DIMETHYLANILINE……2555二甲基苯胺<226>4-EPIANHYDRO-TETRACYCLINE……25564-?-四环素<231>HEA VY METALS……2556重金属<241>IRON……2557铁<251>LEAD……2558铅<261>MERCURY……2558汞<271>READIL Y CARBONIZABLE SUBSTANCES TEST……2560易碳化物检查法<281>RESIDUE ON IGNITION……2560灼烧残渣<291>SELENIUM……2560硒Other Tests and Assays 其它检查法与测定法<301>ACID-NEUTRALIZING CAPACITY……2561酸中和容量<311>ALGINATES ASSAY……2562藻酸盐测定法<331>AMPHETAMINE ASSAY……2562苯丙胺测定法<341> ANTIMICROBIAL AGENTS—CONTENT……2563 抗菌剂-含量<345> Assay for Citric Acid/Citrate and Phosphate……2565 柠檬酸/柠檬酸盐和磷酸盐的测定<351>ASSAY FOR STEROIDS……2565类固醇(甾类化合物)测定法<361> BARBITURATE ASSAY……2565 巴比妥类药物测定法<371>COBALAMIN RADIOTRACER ASSAY……2566钴铵素放射性跟踪剂测定法<381>ELASTOMERIC CLOSURES FOR INJECTIONS……2567 注射剂的弹性密封件<391>EPINEPHRINE ASSAY……2567肾上腺测定法<401>FATS AND FIXED OILS……2568脂肪与混合油<411>FOLIC ACID ASSAY……2571叶酸测定法<425>IODOMETRIC ASSAY—ANTIBIOTICS……2572碘量检查法-抗生素<429>LIGHT DIFFRACTION MEASUREMENT OF PARTICLE SIZE (2572)粒子尺寸的光衍射测量<431>METHOXY DETERMINA TION……2575甲氧基测定法<441>NIACIN OR NIACINAMIDE ASSAY……2576烟酰或烟酰胺测定法<451>NITRITE TITRATION……2578亚硝酸盐滴定<461>NITROGEN DETERMINA TION……2578氮测定法<466>ORDINARY IMPURITIES……2579一般杂质<467>ORGANIC VOLATILE IMPURITIES……2580有机的易挥发杂质<471>OXYGEN FLASK COMBUSTION……2590氧瓶燃烧法<481>RIBOFLAVIN ASSAY……2590核黄素测定法<501>SALTS OF ORGANIC NITROGENOUS BASES……2591有机氮盐<511>SINGLE-STEROID ASSAY……2591单一的类固醇测定法<521>SULFONAMIDES……2592磺胺制剂<531>THIAMINE ASSAY……2593硫胺素测定法<541>TITRIMETRY……2593滴定法<551>ALPHA TOCOPHEROL ASSAY……2596α-维生素E测定法<561>ARTICLES OF BOTANICAL ORIGIN……2596植物起源的药品<563>IDENTIFICATION OF ARTICLES OF BOTANICAL ORIGIN……2603植物药品的鉴别<565>BOTANICAL EXTRACTS……2609植物提取<571>VITAMIN A ASSAY……2611维生素A的测定法<581>VITAMIN D ASSAY……2612维生素D的测定法<591>ZINC DETERMINATION……2616锌的测定法Physical Test and Determinations物理检查与测定法INHALERS, AND DRY POWDER <601>AEROSOLS, NASAL SPRAYS,USP28METERED-DOSEINHALERS……2617气溶胶,鼻用喷雾剂,定量吸入器与干粉吸入器<611>ALCOHOL DETERMINATION……2637乙醇测定法<616>BULK DENSITY AND TAPPED DENSITY……2638堆密度与拍实密度<621>CHROMATOGRAPHY…….2639色谱法<631>COLOR AND ACHROMICITY……2651呈色与消色<641>COMPLETENESS OF SOLUTION……2652完全溶解<643>TOTAL ORGANIC CARBON……2652总有机碳<645>WA TER CONDUCTIVITY……2653水电导率<651>CONGEALING TEMPERA TURE……2654凝点温度<661>CONTAINERS……2655容器<671>CONTAINERS—PERMEATION……2663容器-渗透<691>COTTON……2664棉花<695>CRYSTALLINITY……2665结晶性<696>Crystallinity Determination By Solution Calorimetry……2666 通过溶液量热学测定结晶性<698>DELIVERABLE VOLUME……2667可转移的体积<699>DENSITY OF SOLIDS……2669固体密度<701>DISINTEGRATION……2670崩解时限***<701>Disintegration (Harmonized Chapter, Official April 1,2006)………..2671崩解时限(协调的章节,法定日期,2006.4.1)<711>DISSOLUTION……2673 溶出度***<711>Dissolution (Harmonized Chapter, Official April 1,2006)………..2675 溶出度(协调的章节,法定日期,2006.4.1)<721>DISTILLING RANGE……2682馏程<724>DRUG RELEASE……2682药物释放度***<724>Drug releasee (Harmonized Chapter, Official April 1,2006)………..2690药物释放度(协调的章节,法定日期,2006.4.1)<726>ELECTROPHORESIS……2694电泳<727>CAPILLARY ELECTROPHORESIS……2696毛细管电泳法***<730>Plasma Spectrochemistry….2700 血浆光谱化学<731>LOSS ON DRYING……2704干燥失重<733>LOSS ON IGNITION……2704灼烧失重<736>MASS SPECTROMETRY……2705 质谱<741>MELTING RANGE OR TEMPERATURE……2708熔距或熔点<751>METAL PARTICLES IN OPHTHALMIC OINTMENTS……2709眼用软膏中的金属粒子<755>MINIMUM FILL……2710最低装填量<761>NUCLEAR MAGNETIC RESONANCE……2710核磁共振<771>OPHTHALMIC OINTMENTS……2715眼用软膏<776>OPTICAL MICROSCOPY……2716光学显微镜<781>OPTICAL ROTATION……2718旋光<785>OSMOLALITY AND OSMOLARITY……2718同渗重摩与同渗容摩<786>PARTICLE SIZE DISTRIBUTION ESTIMATION BY ANAL YTICAL SIEVING (2720)通过筛分法估算粒子分布<788>PARTICULATE MATTER IN INJECTIONS……2722注射剂中的颗粒<789>PARTICULATE MATTER IN OPHTHALMIC SOLUTIONS……2729眼用溶液中的颗粒<791>pH (2730)<795>PHARMACEUTICAL COMPOUNDING—NONSTERILE PREPARATIONS (2731)药物混合-非无菌制剂<797>PHARMACEUTICAL COMPOUNDING—STERILE PREPARATIONS (2735)药物混合-无菌制剂<801>POLAROGRAPHY……2752极谱法<811>POWDER FINENESS……2754粉剂细度<821>RADIOACTIVITY……2755放射性<823>RADIOPHARMACEUTICALS FOR POSITRON EMISSION TOMOGRAPHY —COMPOUNDING……2763用于正电子发射断层摄影术的放射性药物<831>REFRACTIVE INDEX……2766折光率<841>SPECIFIC GRA VITY……2766比重<846>SPECIFIC SURFACE AREA……2767 比表面积<851>SPECTROPHOTOMETRY AND LIGHT-SCA TTERING……2770分光光度计与光散射<861>SUTURES—DIAMETER…2775缝线-直径<871>SUTURES—NEEDLE ATTACHMENT……2775缝线-穿孔实验<881>TENSILE STRENGTH…..2776张力<891>THERMAL ANAL YSIS……2776热分析<905>UNIFORMITY OF DOSAGE UNITS……2778制剂单位的含量均匀度<905>UNIFORMITY OF DOSAGE UNITS (Harmonized Chapter, Official April 1,2006)……2780制剂单位的含量均匀度(协调的章节2006.4.1)<911>VISCOSITY……2785粘度<921>WA TER DETERMINA TION……2785水测定法<941>X-RAY DIFFRACTION……2788X光衍射General Information通用信息<1010>ANAL YTICAL DATA—INTERPRETA TION AND TREATMENT (2790)分析数据-解释与处理<1015>AUTOMA TED RADIOCHEMICAL SYNTHESIS APPARATUS (2801)放射性自动合成装置<1031>THE BIOCOMPATIBILITY OF MATERIALS USED IN DRUG CONTAINERS, MEDICAL DEVICES, AND IMPLANTS (2802)用于药物容器、医疗设施和植入剂的材料的生物相容性<1035>BIOLOGICAL INDICATORS FOR STERILIZATION……2811灭菌用生物指示剂<1041>BIOLOGICS……2814生物制剂***<1043>Ancillary Material for Cell, Gene, and Tissue-Engineered Products…….2814 细胞,基因与组织设计产品的辅助材料<1045>BIOTECHNOLOGY-DERIVED ARTICLES……2821生物技术提取产品<1046>CELL AND GENE THERAPY PRODUCTS……2831细胞与基因治疗产品<1047>BIOTECHNOLOGY-DERIVED ARTICLES—TESTS……2858生物技术产品-检查法<1048>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANAL YSIS OF THE EXPRESSION CONSTRUCT IN CELLS USED FOR PRODUCTION OF r-DNA DERIVED PROTEIN PRODUCTS1 (2883)生物产品质量:从蛋白质产品中提取的r-DNA产品在细胞中表达结构的分析<1049>QUALITY OF BIOTECHNOLOGICAL PRODUCTS: STABILITY TESTING OF BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS1 (2884)生物技术产品的质量:生物技术/生物产品的稳定性实验<1050>VIRAL SAFETY EV ALUA TION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN (2887)从人或动物细胞中提取的生物技术产品的病毒安全性评估<1051>CLEANING GLASS APPARATUS……2896玻璃容器的清洗<1061>COLOR—INSTRUMENTAL MEASUREMENT……2896显色-仪器测量***<1065>Ion Chromatography………2898 离子色谱法<1074>EXCIPIENT BIOLOGICAL SAFETY EV ALUA TION GUIDELINES (2900)赋形剂(辅料)生物安全性评估指导<1075>GOOD COMPOUNDING PRACTICES……2903好的混合操作<1078>GOOD MANUFACTURING PRACTICES FOR BULK PHARMACEUTICAL EXCIPIENTS (2906)批药品赋形剂的生产管理规范***<1079>Good Storage and Shipping Practices……2915 良好的贮存与船运规范<1081>GEL STRENGTH OF GELATIN……2920白凝胶的凝胶强度<1086>IMPURITIES IN OFFICIAL ARTICLES……2920药典物品中的杂质<1087>INTRINSIC DISSOLUTION……2923内部的溶出度<1088>IN VITRO AND IN VIVO EV ALUA TION OF DOSAGE FORMS (2924)体内与体外的剂型的评估<1090>IN VIVO BIOEQUIV ALENCE GUIDANCES……29291体内生物等效性指导<1091>LABELING OF INACTIVE INGREDIENTS……2968非活性成分的标示<1101>MEDICINE DROPPER……2969医用滴管<1111>MICROBIOLOGICAL ATTRIBUTES OF NONSTERILE PHARMACEUTICAL PRODUCTS (2969)非无菌药品中的微生物分布<1116>MICROBIOLOGICAL EV ALUA TION OF CLEAN ROOMS AND OTHER CONTROLLED ENVIRONMENTS……2969洁净的房间与其它可控环境的微生物评估<1118>MONITORING DEVICES—TIME, TEMPERATURE, AND HUMIDITY (2976)监控装置-时间、温度与湿度<1119>NEAR-INFRARED SPECTROPHOTOMETRY……2979近红外分光光度测定法***<1120>Raman Spectrophotometry……..2983 Raman分光光度测定法<1121>NOMENCLATURE……2988命名***<1136>Packaging-Unit-of-Use……2989包装-单元使用<1146>PACKAGING PRACTICE—REPACKAGING A SINGLE SOLID ORAL DRUG PRODUCT INTO A UNIT-DOSE CONTAINER……2990 包装操作-将单一固体口服药品产品再包装成单元剂量<1150>PHARMACEUTICAL STABILITY……2994药物稳定性<1151>PHARMACEUTICAL DOSAGE FORMS……2996药物剂型<1160>PHARMACEUTICAL CALCULATIONS IN PRESCRIPTION COMPOUNDING (3006)按处方混合的药物的计算<1171>PHASE-SOLUBILITY ANAL YSIS……3016相溶解分析***<1174>Powder Flow….3017 粉末流动性<1176>PRESCRIPTION BALANCES AND VOLUMETRIC APPARATUS….3020 处方天平与容量器具***<1177>Good Packaging Practices….3021 良好的包装操作***<1178>Good Repackaging Practices….3023 良好的再包装操作<1181>SCANNING ELECTRON MICROSCOPY……3025扫描电子显微镜<1191>STABILITY CONSIDERATIONS IN DISPENSING PRACTICE……3029 分装操作中稳定性考察<1196>PHARMACOPEIAL HARMONIZATION……3031药典的一致性<1207>STERILE PRODUCT PACKAGING—INTEGRITY EV ALUATION (3035)无菌产品包装-完整性评估<1208>STERILITY TESTING—V ALIDATION OF ISOLATOR SYSTEMS (3037)无菌实验-隔离系统的验证<1209>STERILIZATION—CHEMICAL AND PHYSICOCHEMICAL INDICATORS AND INTEGRATORS……3040灭菌-化学与物理化学的指示剂以及二者的综合<1211>STERILIZATION AND STERILITY ASSURANCE OF COMPENDIAL ARTICLES (3041)药典物品中的灭菌与灭菌保证<1216>TABLET FRIABILITY……3046片剂的脆碎度<1221>TEASPOON……3047茶匙<1222>TERMINALL Y STERILIZED PHARMACEUTICAL PRODUCTS—PARAMETRIC RELEASE……3047最终灭菌产品-放行参数<1225>V ALIDATION OF COMPENDIAL METHODS……3050药典方法的验证<1227>V ALIDATION OF MICROBIAL RECOVERY FROM PHARMACOPEIAL ARTICLES (3053)从药物中回收微生物的验证<1230>W ATER FOR HEALTH APPLICATIONS……3055健康用水<1231>W ATER FOR PHARMACEUTICAL PURPOSES……3056制药用水<1241>W ATER–SOLID INTERACTIONS IN PHARMACEUTICAL SYSTEMS (3074)在药物系统中水与固体的相互作用<1251>WEIGHING ON AN ANAL YTICAL BALANCE……3076关于分析天平的称重***<1265>Written Prescription Drug Information-Guidelines……….3078 书面的处方药信息-指南Dietary Supplements营养补充剂General Tests and Assays 一般检查法与测定法<2021>MICROBIAL ENUMERATION TESTS—NUTRITIONAL AND DIETARY SUPPLEMENTS (3080)微生物数量实验-营养与食品添加剂<2022>MICROBIOLOGICAL PROCEDURES FOR ABSENCE OF SPECIFIED MICROORGANISMS—NUTRITIONAL AND DIETARY SUPPLEMENTS (3083)不得检出特定微生物的程序-营养与营养补充剂<2023>MICROBIOLOGICAL A TTRIBUTES OF NONSTERILE NUTRITIONAL AND DIETARY SUPPLEMENTS……3087非无菌的营养与食品添加剂中的微生物分布<2040>DISINTEGRATION AND DISSOLUTION OF DIETARY SUPPLEMENTS (3089)食品添加剂的崩解与溶出<2091>WEIGHT VARIATION OF DIETARY SUPPLEMENTS……3092食品添加剂的重量差异<2750>MANUFACTURING PRACTICES FOR DIETARY SUPPLEMENTS (3093)食品添加剂的生产操作。

美国FDA药品质量控制微生物实验室检查指南1993年

美国FDA药品质量控制微生物实验室检查指南1993年

美国FDA药品质量控制微生物实验室检查指南1993年I.导言《药品质量控制实验室检查指南》主要涉及许多有关药品实验室分析的化学方面的问题,对微生物实验室的检查仅提供了有限的指导,而本指南则是微生物分析检查过程的指导。

本指南建议,如同对任何实验室检查—样,在检查微生物实验室时,应有—名熟悉检验的分析学家(微生物学家)参与。

II.非无菌药品的微生物检验由于种种原因,局部药品、滴鼻剂和吸入剂存在许多微生物污染方面的问题.美国药典‘‘微生物属性”章(1111)指出“应该从药品用法、药品性质及时患者的潜在危害等方面评价微生物在非无菌药品中的重要性”,除此之外,没有提供具体的指导。

美国药典还建议应对某些种类的非无菌药品做常规的总菌数检验及某些特定的污染指示微生物的检验:例如:植物、动物和某些矿物质中的沙门氏菌属;口服液体中的大肠杆菌;局部用药品小的金黄色倘萄球菌和绿脓杆菌污染;以及:自肠、尿道、阴道用药中的酵母菌和霉菌:大量的专题文章还沦及厂微生物的限度。

作为非无菌药品受微生物污染的可接受程度和类型的—般性指导,美国食品和药品管理局药品分局的邓尼根博士曾强调其对健康的危害问题。

1970年他提出被革兰氏阴性细菌污染的局部制剂可能引起中度至重度的健康危害:文献和调查表明,许多感染都源于这种局部药品的革兰氏阴性细菌污染。

几年前马萨诸塞州的—家医院就报道过—宗络合碘(Povidonelodine)被洋葱假恤孢菌(Pseudomonas cepacia)污染的典型病例。

因此,每家公司都希望为自己的非无菌药品制订出一种关于微生物限度的标准,美国药典中“微生物限度”(USP61)提供了检验几种指示微生物的方法,但并末涉及所有有害微生物。

例如医药界普遍认为,洋葱假中孢菌在局部药品或滴鼻剂斗,大量存在是有害的,但美国药典没有提供证明这种微生物存在的检验方法。

间羟异丙肾上腺素硫酸盐吸入剂溶液的收回就是这方面的—个例子。

美国药典第XⅫ版各论部分没有要求对这种药品进行微生物检验。

USP微生物限度检查 中文

USP微生物限度检查 中文

USP微生物限度检查中文61)微生物限度检测(MICROBIAL LIMIT TESTS)此章提供方法来检测可能存在的好氧微生物其他制药过程中可能出现的微生物的数量,包括原材料和成品中的。

如果经过验证确认可以得到相同或更好的检测结论,也允许采用自动化的检测方法。

在样品检测过程中须进行无菌操作。

若无特别说明,则“培养(incubate)”一词指在30—35℃的培养箱内培养24至48小时;“生长(growth)”一词用于专门的判定,说明“存在和可能存在活的微生物”。

准备实验 (Preparatory Testing)本章涉及实验结果的有效性取决于:提供的被检测样品本身在实验条件下,被充分证明不会抑制可能存在的微生物的生长。

因此,在准备样品时,需要正规的实验操作和符合要求的实验条件,接种稀释样品到含有以下(微生物)培养物的培养基:金黄色(奥里斯)葡萄球菌(Staphylococcus aureus),大肠埃希氏菌(Escherichia coli), 铜绿假单胞菌(Pseudomonas aeruginosa), 和沙门氏菌(Salmonella)。

方法如下:将用肉汤培养基培养24小时后的(微生物)不小于10-3稀释的微生物培养物,加1 ml(微生物)培养液到磷酸(盐)缓冲液(pH 7.2),液体大豆酪蛋白消化物培养基(Fluid Soybean-Casein Digest Medium),或者液体乳糖培养基(Fluid Lactose Medium)。

相应培养基培养失败则需要采取以下方法更改检测程序:(1)增加稀释液体积,检测样品加入量仍维持不变;或者(2)中和一定数量的干扰因子;或者(3)结合(1)、(2)得出适当条件,使接种物得以生长。

以下是一些物质的成分和浓度,该物质及浓度可用于加入培养基、阻止物质发挥抑菌作用:大豆卵磷脂(soy lecithin, 0.5%)或者聚山梨醇酯20(polysorbate 20, 4.0%)。

微生物限度检验(USP29)

微生物限度检验(USP29)

61MICROBIAL LIMIT TESTS微生物限度检测This chapter provides tests for the estimation of the number of viable aerobic microorganisms present and for freedom from designated microbial species in pharmaceutical articles of all kinds, from raw materials to the finished forms. An automated method may be substituted for the tests presented here, provided it has been properly validated as giving equivalent or better results. In preparing for and in applying the tests, observe aseptic precautions in handling the specimens. Unless otherwise directed, where the procedure specifies simply ―incubate,‖ hold the container in air thatis thermostatically controlled at a temperature between 30 and 35 , for a period of 24 to 48 hours. The term ―growth‖ is used in a special sense herein, i.e., to designate the presence and presumed proliferation of viable microorganisms.本章提供了对现存的需氧活菌计数的判断和对药品从原料到成品中、药学上所有控制菌规定的检查方法。

USP微生物限度检查 中文

USP微生物限度检查 中文

USP微生物限度检查中文61)微生物限度检测(MICROBIAL LIMIT TESTS)此章提供方法来检测可能存在的好氧微生物其他制药过程中可能出现的微生物的数量,包括原材料和成品中的。

如果经过验证确认可以得到相同或更好的检测结论,也允许采用自动化的检测方法。

在样品检测过程中须进行无菌操作。

若无特别说明,则“培养(incubate)”一词指在30—35℃的培养箱内培养24至48小时;“生长(growth)”一词用于专门的判定,说明“存在和可能存在活的微生物”。

准备实验 (Preparatory Testing)本章涉及实验结果的有效性取决于:提供的被检测样品本身在实验条件下,被充分证明不会抑制可能存在的微生物的生长。

因此,在准备样品时,需要正规的实验操作和符合要求的实验条件,接种稀释样品到含有以下(微生物)培养物的培养基:金黄色(奥里斯)葡萄球菌(Staphylococcus aureus),大肠埃希氏菌(Escherichia coli), 铜绿假单胞菌(Pseudomonas aeruginosa), 和沙门氏菌(Salmonella)。

方法如下:将用肉汤培养基培养24小时后的(微生物)不小于10-3稀释的微生物培养物,加1 ml(微生物)培养液到磷酸(盐)缓冲液(pH 7.2),液体大豆酪蛋白消化物培养基(Fluid Soybean-Casein Digest Medium),或者液体乳糖培养基(Fluid Lactose Medium)。

相应培养基培养失败则需要采取以下方法更改检测程序:(1)增加稀释液体积,检测样品加入量仍维持不变;或者(2)中和一定数量的干扰因子;或者(3)结合(1)、(2)得出适当条件,使接种物得以生长。

以下是一些物质的成分和浓度,该物质及浓度可用于加入培养基、阻止物质发挥抑菌作用:大豆卵磷脂(soy lecithin, 0.5%)或者聚山梨醇酯20(polysorbate 20, 4.0%)。

微生物限度方法学

微生物限度方法学

微生物限度方法学
微生物限度方法学(Microbial limit testing)是一种用于确定给定产品中微生物数量的方法。

微生物限度测试通常用于食品、药品、化妆品和其他生物制品的质量控制。

微生物限度方法学包括以下步骤:
1. 样品准备:从待测试产品(如食品、药品等)中取样,以确保样品的代表性。

2. 来源分离:将样品分离成适当的处理单位(如重量、体积等),以便进行微生物分析。

3. 培养基准备:根据需要,准备适当的培养基,以促进微生物的生长。

4. 培养:将处理单位接种到培养基上,并在适当的温度和时间下培养。

5. 计数:在培养结束后,通过计数可见的微生物菌落数量来确定微生物限度。

6. 鉴定:根据需要,对生长的菌落进行鉴定,以确定微生物的种类。

7. 确认:在鉴定后,需要进行进一步的确认测试,以确保微生物的结果准确可靠。

微生物限度方法学的目标是确定给定产品中的微生物数量是否符合法规和规定的要求。

通过微生物限度测试,可以确定产品的微生物质量,并确保产品的安全性和有效性。

USP微生物试验

USP微生物试验

E. coli
10倍稀釋檢液( TSB )
預備試驗
檢測試驗
將稀釋檢液加菌培養在 30~35℃,18 ~ 24小時
稀釋檢液培養在30~35℃ ,18 ~ 24小時
取1 mL稀釋液,接種於100 mL MacConkey Broth,於42~ 44℃培養24 ~ 48小時
劃線接種到MacConkey Agar 上 ,30~35℃培養18 ~ 72小時。
生長及區分
綠膿桿菌 Cetrimide Agar
P. aeruginosa:生長及區分 E. coli:抑制
Pseudomonas agar P 金黃色葡萄球菌 Mannitol Salt Agar
P. aeruginosa:生長及區分 E. coli:抑制
S. aureus:生長及區分 E. coli:抑制
Growth promotion and Inhibitory properties of the media
測試培養基
測試菌種及特性
大腸桿菌
MacConkey Broth
E. coli:生長、S. aureus:抑制
MacConkey Agar 沙門氏菌
E. coli:生長及區分
Rappaport-Vassiliadis Broth
新USP/EP/JP 藥典微生 物檢驗方法
USP Microbial Limits
Microbial Limit Tests” into two chapters:
<61> Microbial Enumeration Tests: Total aerobic microbial count (TAMC)-嗜氧性總生菌數 Total combined yeasts and molds count (TYMC)- 總黴菌及總酵母菌數

USP-微生物限度检查

USP-微生物限度检查

〈61〉MICROBIAL LIMIT TESTSThis chapter provides tests for the estimation of the number of viable aerobic microorganisms present and for freedom from designated microbial species in pharmaceutical articles of all kinds, from raw materials to the finished forms. An automated method may be substituted for the tests presented here, provided it has been properly validated as giving equivalent or better results. In preparing for and in applying the tests, observe aseptic precautions in handling the specimens. Unless otherwise directed, where the procedure specifies simply ―incubate,‖ hold the container in air that is thermostatically controlled ata temperature between 30and 35,for a period of 24to 48hours.The term―growth‖ is used in a special sense herein, i.e., to designate the presence and presumed proliferation of viable microorganisms.PREPARATORY TESTINGThe validity of the results of the tests set forth in this chapter rests largely upon the adequacy of a demonstration that the test specimens to which they are applied do not, of themselves, inhibit the multiplication, under the test conditions, of microorganisms that may be present. Therefore, preparatory to conducting the tests on a regular basis and as circumstances require subsequently, inoculate diluted specimens of the material to be tested with separate viable cultures of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Salmonella. This can be done by adding 1mLof not less than 10-3dilution of a 24-hour broth culture of the microorganism to the first dilution (in pH7.2Phosphate Buffer, Fluid Soybean–Casein Digest Medium, or Fluid Lactose Medium)of the test material and following the test procedure. Failure of the organism(s)to grow in the relevant medium invalidates that portion of the examination and necessitates a modification of the procedure by (1)an increase in the volume of diluent, the quantity of test material remaining the same, or by (2)the incorporation of a sufficient quantityof suitable inactivating agent(s)in the diluents, or by (3)an appropriate combination of modifications (1)and (2)so as to permit growth of the inocula. The following are examples of ingredients and their concentrations that may be added to the culture medium to neutralize inhibitory substances present in the sample: soy lecithin,0.5%;and polysorbate 20,4.0%. Alternatively, repeat the test as described in the preceding paragraph, using Fluid Casein Digest–Soy Lecithin–Polysorbate 20 Medium to demonstrate neutralization of preservatives or other antimicrobial agents in the test material. Where inhibitory substances are contained in the product and the latter is soluble, a suitable, validated adaptation of a procedure set forth in the section Membrane Filtration under Test for Sterility of the Product to be Examined under Sterility Tests 〈71〉,may be used.If in spite of the incorporation of suitable inactivating agents and a substantial increase in the volume of diluent, it is still not possible to recover the viable cultures described above and where the article is not suitable for employment of membrane filtration, it can be assumed that the failure to isolate the inoculated organism is attributable to the bactericidal activity of the product. This information serves to indicate that the article is not likely to be contaminated with the given species of microorganism. Monitoring should be continued in order to establish the spectrum of inhibition and bactericidal activity of the article.BUFFER SOLUTION AND MEDIACulture media may be prepared as follows, or dehydrated culture media may be used provided that, when reconstituted as directed by the manufacturer or distributor, they have similar ingredients and/or yield media comparable to those obtained from the formulas given herein.In preparing media by the formulas set forth herein, dissolve the soluble solids in the water, using heat, if necessary, to effect complete solution, and add solutions of hydrochloric acid or sodium hydroxide in quantities sufficient toyield the desired pH in the medium when it is ready for use. Determine the pH at 25±2.Where agar is called for in a formula, use agar that has a moisture content of not more than 15%.Where water is called for in a formula, use Purified Water.PH7.2Phosphate BufferStock Solution— Dissolve 34g of monobasic potassium phosphate in about 500mLof water contained in a 1000-mLvolumetric flask. Adjust to pH7.2±0.1by the addition of sodium hydroxide TS(about 175mL),add water to volume, and mix. Dispense and sterilize. Store under refrigeration.For use, dilute the Stock Solution with water in the ratio of 1to 800,and sterilize.MediaUnless otherwise indicated, the media should be sterilized by heating in an autoclave (see Steam Sterilization under Sterilization 〈1211〉),the exposure time depending on the volume to be sterilized.I.Fluid Casein Digest–Soy Lecithin–Polysorbate 20MediumDissolve the pancreatic digest of casein and soy lecithin in 960mLof water,heating in a water bath at 48to 50for about 30minutes to effect solution. Add 40mLof polysorbate 20.Mix,and dispense as desired.II.Soybean–Casein Digest Agar MediumpHafter sterilization:7.3±0.2.III.Fluid Soybean–Casein Digest MediumIV.Mannitol–Salt Agar MediumMix,then heat with frequent agitation, and boil for 1minute to effect solution. pHafter sterilization:7.4±0.2.Heat with frequent agitation,and boil for 1minute.Sterilize,cool to between 45and 50,and add 10mLof sterile potassium tellurite solution (1in 100)a nd50mLof egg-yolk emulsion. Mix intimately but gently, and pour into plates. (Prepare the egg-yolk emulsion by disinfecting the surface of whole shell eggs, aseptically cracking the eggs, and separating out intact yolks into a sterile graduated cylinder. Add sterile saline TS to obtain a 3to 7ratio of egg yolk to saline. Add to a sterile blender cup, and mix at high speed for 5seconds.) pHafter sterilization:6.8±0.2.VI.Vogel–Johnson Agar MediumBoil the solution of solids for 1minute.Sterilize,cool to between 45and 50,and add 20mLof sterile potassium tellurite solution (1in 100).pHafter sterilization:7.2±0.2.VII.Cetrimide Agar MediumDissolve all solid components in the water, and add the glycerin. Heat,with frequent agitation, and boil for 1minute to effect solution.pHafter sterilization:7.2±0.2.VIII. Pseudomonas Agar Medium for Detection of FluorescinDissolve the solid components in the water before adding theglycerin.Heat,with frequent agitation,and boil for 1minute to effect solution. pHafter sterilization:7.2±0.2.IX.Pseudomonas Agar Medium for Detection of PyocyaninDissolve the solid components in the water before adding theglycerin.Heat,with frequent agitation,and boil for 1minute to effect solution. pHafter sterilization:7.2±0.2.X.Fluid Lactose MediumCool as quickly as possible after sterilization.pHafter sterilization:6.9±0.2.XI.Fluid Selenite–Cystine MediumFinal pH:7.0±0.2.Mix,and heat to effect solution.Heat in flowing steam for 15minutes.Do not sterilize.XII.Fluid Tetrathionate MediumHeat the solution of solids to boiling. On the day of use, add a solution prepared by dissolving 5g of potassium iodide and 6g of iodine in 20mLof water. Then add 10mLof a solution of brilliant green (1in 1000),a nd mix.Do not heat the medium after adding the brilliant green solution.XIII.Brilliant Green Agar MediumBoil the solution of solids for 1minute.Sterilize just prior to use, melt the medium, pour into petri dishes, and allow to cool.pHafter sterilization:6.9±0.2.XIV. Xylose–Lysine–Desoxycholate Agar MediumFinal pH:7.4±0.2.Heat the mixture of solids and water, with swirling, just to the boiling point. Do not overheat or sterilize. Transfer at once to a water bath maintained at about 50,and pour into plates as soon as the medium has cooled.XV.Bismuth Sulfite Agar MediumFinal pH:7.6±0.2.Heat the mixture of solids and water,with swirling,just to the boiling point.Do not overheat or sterilize.Transfer at once to a water bath maintained at about 50,and pour into plates as soon as the medium has cooled.XVI.Triple Sugar–Iron–Agar MediumpHafter sterilization:7.3±0.2.XVII.MacConkey Agar MediumBoil the mixture of solids and water for 1minute to effect solution.pHafter sterilization:7.1±0.2.XVIII.Levine Eosin–Methylene Blue Agar MediumDissolve the pancreatic digest of gelatin, the dibasic potassium phosphate, and the agar in the water, with warming, and allow to cool. Just prior to use, liquefy the gelled agar solution, add the remaining ingredients, as solutions, in the following amounts, and mix: for each 100mLof the liquefied agar solution—5mLof lactose solution (1in 5),2mLof the eosin Ysolution (1in 50),and 2mLof methylene blue solution (1in 300).The finished medium may not be clear.pHafter sterilization:7.1±0.2.XIX. Sabouraud Dextrose Agar MediumMix,and boil to effect solution.pHafter sterilization:5.6±0.2.XX.Potato Dextrose Agar MediumDissolve by heating,and sterili ze.pHafter sterilization:5.6±0.2.For use, just prior to pouring the plates, adjust the melted and cooled to 45 medium with sterile tartaric acid solution (1in 10)to a pHof 3.5±0.1.Do not reheat the pH3.5medium.SAMPLINGProvide separate 10-mLor 10-g specimens for each of the tests called for in the individual monograph.PROCEDUREPrepare the specimen to be tested by treatment that is appropriate to its physical characteristics and that does not alter the number and kind of microorganisms originally present, in order to obtain a solution or suspension of all or part of it in a form suitable for the test procedure(s)to be carried out. For a solid that dissolves to an appreciable extent but not completely, reduce the substance to a moderately fine powder, suspend it in the vehicle specified, and proceed as directed under Total Aerobic Microbial Count, and under Test for Staphylococcus aureus and Pseudomonas aeruginosa and Test for Salmonella species and Escherichia coli.For a fluid specimen that consists of a true solution, or a suspension in water or a hydroalcoholic vehicle containing less than 30percent of alcohol, and for a solid that dissolves readily and practically completely in 90mLofpH7.2Phosphate Buffer or the media specified, proceed as directed under Total Aerobic Microbial Count,and under Test for Staphylococcus aureus and Pseudomonas aeruginosa and Test for Salmonella species and Escherichia coli.For water-immiscible fluids, ointments, creams, and waxes, prepare a suspension with the aid of a minimal quantity of a suitable, sterile emulsifying agent (such as one of the polysorbates), using a mechanical blender andwarming to a temperature not exceeding 45,if necessary, and proceed with the suspension as directed under Total Aerobic Microbial Count,and under Test for Staphylococcus aureus and Pseudomonas aeruginosa and Test for Salmonella species and Escherichia coli.For a fluid specimen in aerosol form, chill the container in an alcohol-dry ice mixture for approximately 1hour,cut open the container, allow it to reach room temperature, permit the propellant to escape, or warm to drive off the propellant if feasible, and transfer the quantity of test material required for the procedures specified in one of the two preceding paragraphs, as appropriate. Where 10.0g or 10.0mLof the specimen, whichever is applicable, cannot be obtained from 10containers in aerosol form, transfer the entire contents from 10chilled containers to the culture medium, permit the propellant to escape, and proceed with the test on the residues. If the results of the test are inconclusive or doubtful, repeat the test with a specimen from 20more containers.Total Aerobic Microbial CountFor specimens that are sufficiently soluble or translucent to permit use of the Plate Method, use that method; otherwise, use the Multiple-Tube Method. With either method, first dissolve or suspend 10.0g of the specimen if it is a solid, or10mL,accurately measured, if the specimen is a liquid, in pH7.2Phosphate Buffer, Fluid Soybean–Casein Digest Medium,or Fluid Casein Digest–Soy Lecithin-Polysorbate 20Medium to make 100mL.For viscous specimens that cannot be pipeted at this initial 1:10dilution,dilute the specimen until a suspension is obtained,i.e.,1:50or 1:100,etc.,that can be pipeted. Perform the test for absence of inhibitory (antimicrobial)properties as described under Preparatory Testing before the determination of Total Aerobic Microbial Count.Add the specimen to the medium not more than 1hour after preparing the appropriate dilutions for inoculation.PLATE METHODDilute further, if necessary, the fluid so that 1mLwill be expected to yield between 30and 300colonies.Pipet 1mLof the final dilution onto each of two sterile petri dishes. Promptly add to each dish 15to 20mLof Soybean–Casein Digest Agar Medium that previously has been melted and cooled toapproximately 45.Cover the petri dishes, mix the sample with the agar by tilting or rotating the dishes, and allow the contents to solidify at room temperature. Invert the petri dishes, and incubate for 48to 72hours.Following incubation, examine the plates for growth, count the number of colonies, and express the average for the two plates in terms of the number of microorganisms per g or per mLof specimen.If no microbial colonies are recovered from the dishes representing the initial 1:10dilution of the specimen,express the results as ―less than 10microorganisms per g or per mLof specimen.‖MULTIPLE-TUBE METHODInto each of fourteen test tubes of similar size place 9.0mLof sterile Fluid Soybean–Casein Digest Medium. Arrange twelve of the tubes in four sets of three tubes each. Put aside one set of three tubes to serve as the controls. Into each of three t ubes of one set (―100‖)and into a fourth tube (A)pipet 1mLof the solution or suspension of the specimen, and mix. From tube A,pipet 1mLof itscontents into the one remaining tube (B)not included in a set, and mix. These two tubes contain 100mg (or 100µL)and 10mg (or 10µL)of the specimen, respectively. Into each of the second set (―10‖)of three tubes pipet 1mLfrom tube A,and into each tube of the third set (―1‖)pipet 1mLfrom tube B.Discard the unused contents of tubes A and B.Close well,and incubate all of the tubes. Following the incubation period, examine the tubes for growth: the three control tubes remain clear and the observations in the tubes containing the specimen, when interpreted by reference to Table 1,indicate the most probable number of microorganisms per g or per mLof specimen.Table 1.Most Probable Total Count by Multiple-Tube MethodTest for Staphylococcus aureus and Pseudomonas aeruginosaTo the specimen add Fluid Soybean–Casein Digest Medium to make100mL,mix,and incubate. Examine the medium for growth, and if growth is present, use an inoculating loop to streak a portion of the medium on the surface of Vogel–Johnson Agar Medium(or Baird–Parker Agar Medium,or Mannitol–Salt Agar Medium)and of Cetrimide Agar Medium, each plated on petri dishes. Cover and invert the dishes, and incubate. If, upon examination, none of the plates contains colonies having the characteristics listed in Tables 2and 3for the media used, the test specimen meets the requirements for freedom from Staphylococcus aureus and Pseudomonas aeruginosa.Table 2.Morphologic Characteristics of Staphylococcus aureus on SelectiveAgar MediaTable 3.Morphologic Characteristics of Pseudomonas aeruginosa onSelective and Diagnostic Agar MediaCoagulase Test (for Staphylococcus aureus )— With the aid of an inoculating loop, transfer representative suspect colonies from the agar surfaces of the Vogel –Johnson Agar Medium (or Baird –Parker Agar Medium, or Mannitol –Salt Agar Medium)to individual tubes, each containing 0.5mLof mammalian,preferably rabbit or horse, plasma with or without suitable additives. Incubate in a water bath at 37,examining the tubes at 3hours and subsequently at suitable intervals up to 24hours.Test positive and negative controlssimultaneously with the unknown specimens. If no coagulation in any degree is observed, the specimen meets the requirements of the test for absence of Staphylococcus aureus .Oxidase and Pigment Tests (for Pseudomonas aeruginosa )— With the aid of an inoculating loop, streak representative suspect colonies from the agarsurface of Cetrimide Agar Medium on the agar surfaces of Pseudomonas Agar Medium for Detection of Fluorescin and Pseudomonas Agar Medium forDetection of Pyocyanin contained in petri dishes. If numerous colonies are to be transferred, divide the surface of each plate into quadrants, each of which may be inoculated from a separate colony. Cover and invert the inoculated media, and incubate at 35±2for not less than three days.Examine thestreaked surfaces under UVlight. Examine the plates to determine whether colonies having the characteristics listed in Table 3are present.Confirm any suspect colonial growth on one or more of the media asPseudomonas aeruginosa by means of the oxidase test. Upon the colonialgrowth place or transfer colonies to strips or disks of filter paper that previously has been impregnated with N,N-dimethyl-p-phenylenediamine dihydrochloride: if there is no development of a pink color, changing to purple, the specimen meets the requirements of the test for the absence of Pseudomonas aeruginosa. The presence of Pseudomonas aeruginosa may be confirmed by other suitable cultural and biochemical tests, if necessary.Test for Salmonella species and Escherichia coliTo the specimen, contained in a suitable vessel, add a volume of Fluid Lactose Medium to make 100mL,and incubate. Examine the medium for growth, and if growth is present, mix by gently shaking. Pipet 1-mLportions into vessels containing,respectively,10mLof Fluid Selenite–Cystine Medium and Fluid Tetrathionate Medium, mix, and incubate for 12to 24hours.(Retain the remainder of the Fluid Lactose Medium.)Test for Salmonella Species— By means of an inoculating loop, streak portions from both the selenite-cystine and tetrathionate media on the surface of Brilliant Green Agar Medium, Xylose–Lysine–Desoxycholate Agar Medium, and Bismuth Sulfite Agar Medium contained in petri dishes. Cover and invert the dishes, and incubate. Upon examination, if none of the colonies conforms to the description given in Table 4,the specimen meets the requirements of the test for absence of the genus Salmonella.Table 4.Morphologic Characteristics of Salmonella Species on Selective AgarMediaIf colonies of Gram-negative rods matching the description in Table 4are found, proceed with further identification by transferring representative suspect colonies individually, by means of an inoculating wire, to a butt-slant tube of Triple Sugar–Iron–Agar Medium by first streaking the surface of the slant and then stabbing the wire well beneath the surface. Incubate. If examination discloses no evidence of tubes having alkaline (red)slants and acid (yellow)butts (with or without concomitant blackening of the butt from hydrogen sulfide production),the specimen meets the requirements of the test for the absence of the genus Salmonella.*Test for Escherichia coli— By means of an inoculating loop, streak a portion from the remaining Fluid Lactose Medium on the surface of MacConkey Agar Medium. Cover and invert the dishes, and incubate. Upon examination, if none of the colonies conforms to the description given in Table 5for this medium, the specimen meets the requirements of the test for absence of Escherichia coli. Table 5.Morphologic Characteristics of Escherichia coli on MacConkey AgarMediumIf colonies matching the description in Table 5are found, proceed with further identification by transferring the suspect colonies individually, by means of an inoculating loop, to the surface of Levine Eosin–Methylene Blue Agar Medium, plated on petri dishes. If numerous colonies are to be transferred, divide the surface of each plate into quadrants, each of which may be seeded from a separate colony. Cover and invert the plates, and incubate. Upon examination, if none of the colonies exhibits both a characteristic metallic sheen under reflected light and a blue-black appearance under transmitted light, the specimen meets the requirements of the test for the absence of Escherichia coli. The presence of Escherichia coli may be confirmed by further suitable cultural and biochemical tests.Total Combined Molds and Yeasts CountProceed as for the Plate Method under Total Aerobic Microbial Count, except for using the same amount of Sabouraud Dextrose Agar Medium or Potato Dextrose Agar Medium, instead of Soybean Casein Digest Medium, andexcept for incubating the inverted petri dishes for 5to 7days at 20to 25.RetestFor the purpose of confirming a doubtful result by any of the procedures outlined in the foregoing tests following their application to a 10.0-g specimen, a retest on a 25-g specimen of the product may be conducted. Proceed as directed for Procedure, but make allowance for the larger specimen size.微生物限度检查本章节提供了用于评估存在制药过程中,从原料到制剂的需氧微生物和其他指定微生物菌种的数量的检查方法。

USP 61 微生物限度检测——计数法

USP 61 微生物限度检测——计数法
3. ENUMERATION METHODS计数方法
Use the Membrane Filtration method or one of the Plate-Count Methods, as directed. The Most-
Probable-Number (MPN) Method is generally the least accurate method for microbial counts; however, for certain product groups with very low bioburden, it may be the most appropriate method.
2. GENERAL PROCEDURES通用规程
Carry out the determination under conditions designed to avoid extrinsic microbial contamination of the product to be examined. The precautions taken to avoid contamination must be such that they do not affect any microorganisms that are to be revealed in the test. 微生物计数环境应能防止外来微生物对供试品的污染。防止污染的措施不能影响供试品中微生物 的检出。
<61>MICONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS
非无菌产品微生物限度检查:微生物计数法
1. INTRODUCTION导言
The tests described hereafter will allow quantitative enumeration of mesophilic bacteria and fungi that may grow under aerobic conditions. 微生物计数法系用于能在有氧条件下生长的嗜温细菌和霉菌的定量计数。

微生物限度 英语

微生物限度 英语

微生物限度英语
"微生物限度"的英语表述可以是 "Microbial limit" 或 "Microbial limit test",通常用于描述药品、食品、化妆品等产品中允许存在的微生物数量的上限。

在药品生产和质量控制中,微生物限度是一个重要的指标,用于确保产品的安全性和稳定性。

微生物限度测试是一种常用的方法,用于检测产品中微生物的数量和种类,以判断其是否符合规定的标准。

在食品和化妆品行业中,微生物限度也同样重要,因为过量的微生物可能导致产品腐败、变质或对人体健康造成危害。

因此,这些行业通常会制定微生物限度标准,并采取相应的措施来控制和检测微生物的数量。

除了 "Microbial limit" 和 "Microbial limit test" 之外,还可以使用其他类似的表达方式,如 "Microbial count limit" 或 "Microbial contamination limit",具体取决于上下文和使用领域。

总的来说,"微生物限度"是一个与微生物数量相关的概念,用于确保产品的质量和安全性。

在不同的行业中,可能会有特定的术语和标准来定义和控制微生物限度。

微生物限度检验PPT课件

微生物限度检验PPT课件
- 表面活性剂、中和剂或灭活剂:应证明其有效性及 对微生物的生长和存活无影响。
- 供试液从制备至加入检验用培养基,不得超过1小 时。
- 供试液制备若需用水浴加温时,温度不应超过45℃。 - 供试液的体积:100ml。
13
稀释剂( 中国药典2005版)
(1) 氯化钠-蛋白胨缓冲溶液 (2) 无菌磷酸盐缓冲液 (3) 无菌磷酸盐缓冲液
中国药典2005版
菌株名称
CMCC编号
大肠埃希氏菌(E. coli)
CMCC(B)44102
金黄色葡萄球菌(Sta. aureus) CMCC(B)26003
枯草芽孢杆菌(Bac. subtilis)
CMCC(B)63501
白色念珠菌(Can. albicans) 黑曲霉菌(Asp. niger)
CMCC(F)98001 CMCC(F)98003
一次检出为准
第一次结果超过规定标准,复 试两次,三次结果平均报告
不符合标准规定,取大于25g的 样品复试
不符合标准规定,取大于25g的 样品复试
一次检出为准
测定结果在规定的限度标准5 倍以内均为合格
6
验证目的
- 在于确认(寻找)一种有效的检验方法,如果样 品(药品)中有一定数量的微生物存在,那么采 用此法可以使得样品(药品)中的微生物得以检 出。
过滤
5x102 cfu/ml菌悬液 0.1 ml
菌种组:
5x102 cfu/ml菌悬液 0.1 ml
过滤
空白样品组:
过滤
计数A 计数B (阴性对照) 计数C (阳性对照) 计数D
- 充分验证样品(药品)本身对微生物生长的影响。
7
验证目的
确认一种检验方法。 验证实验 检验条件

USP61

USP61

非无菌产品微生物学检查:微生物计数检查法USP61中英对照版<61> MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIALENUMENRATION TESTS非无菌产品微生物学检查:微生物计数检查法INTRODUCTION 导言The tests described hereafter will allow quantitative enumeration of mesophilic bacteria and fungi that may grow under aerobic conditions.以下所描述的这些检测将使得对在有氧的条件下生长的嗜温性细菌和真菌进行定量计数成为可能。

The tests are designed primarily to determine whether a substance or preparation complies with an established specification for microbiological quality. When used for such purposes, follow the instructions given below, including the number of samples to be taken, and interpret the results as stated below.这些检测主要设计用于测定一种物质或制备品是否符合已确立的微生物质量标准。

当用于此类目的时,需遵照以下所给的说明,包括待取样品的数量,并且按照下面所述解释结果。

The methods are not applicable to products containing viable microorganisms as active ingredients.这些方法不适用于以活菌作为活性成分的产品。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

〈61〉 MICROBIAL LIMIT TESTSThis chapter provides tests for the estimation of the number of viable aerobic microorganisms present and for freedom from designated microbial species in pharmaceutical articles of all kinds, from raw materials to the finished forms. An automated method may be substituted for the tests presented here, provided it has been properly validated as giving equivalent or better results. In preparing for and in applying the tests, observe aseptic precautions in handling the specimens. Unless otherwise directed, where the procedure specifies simply ―incubate,‖ hold the container in air that is thermostatically controlled ata temperature between 30and 35, for a period of 24 to 48 hours. The term ―growth‖ is used in a special sense herein, i.e., to designate the presence and presumed proliferation of viable microorganisms.PREPARATORY TESTINGThe validity of the results of the tests set forth in this chapter rests largely upon the adequacy of a demonstration that the test specimens to which they are applied do not, of themselves, inhibit the multiplication, under the test conditions, of microorganisms that may be present. Therefore, preparatory to conducting the tests on a regular basis and as circumstances require subsequently, inoculate diluted specimens of the material to be tested with separate viable cultures of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Salmonella. This can be done by adding 1 mL of not less than 10-3 dilution of a 24-hour broth culture of the microorganism to the first dilution (in pH 7.2 Phosphate Buffer, Fluid Soybean–Casein Digest Medium, or Fluid Lactose Medium) of the test material and following the test procedure. Failure of the organism(s) to grow in the relevant medium invalidates that portion of the examination and necessitates a modification of the procedure by (1) an increase in the volume of diluent, the quantity of test material remaining the same, or by (2) the incorporation of a sufficient quantityof suitable inactivating agent(s) in the diluents, or by (3) an appropriate combination of modifications (1) and (2) so as to permit growth of the inocula. The following are examples of ingredients and their concentrations that may be added to the culture medium to neutralize inhibitory substances present in the sample: soy lecithin, 0.5%; and polysorbate 20, 4.0%. Alternatively, repeat the test as described in the preceding paragraph, using Fluid Casein Digest–Soy Lecithin–Polysorbate 20 Medium to demonstrate neutralization of preservatives or other antimicrobial agents in the test material. Where inhibitory substances are contained in the product and the latter is soluble, a suitable, validated adaptation of a procedure set forth in the section Membrane Filtration under Test for Sterility of the Product to be Examined under Sterility Tests 〈71〉, may be used.If in spite of the incorporation of suitable inactivating agents and a substantial increase in the volume of diluent, it is still not possible to recover the viable cultures described above and where the article is not suitable for employment of membrane filtration, it can be assumed that the failure to isolate the inoculated organism is attributable to the bactericidal activity of the product. This information serves to indicate that the article is not likely to be contaminated with the given species of microorganism. Monitoring should be continued in order to establish the spectrum of inhibition and bactericidal activity of the article.BUFFER SOLUTION AND MEDIACulture media may be prepared as follows, or dehydrated culture media may be used provided that, when reconstituted as directed by the manufacturer or distributor, they have similar ingredients and/or yield media comparable to those obtained from the formulas given herein.In preparing media by the formulas set forth herein, dissolve the soluble solids in the water, using heat, if necessary, to effect complete solution, and add solutions of hydrochloric acid or sodium hydroxide in quantities sufficient toyield the desired pH in the medium when it is ready for use. Determine the pHat 25 ± 2.Where agar is called for in a formula, use agar that has a moisture content of not more than 15%. Where water is called for in a formula, use Purified Water.PH 7.2 Phosphate BufferStock Solution— Dissolve 34 g of monobasic potassium phosphate in about 500 mL of water contained in a 1000-mL volumetric flask. Adjust to pH 7.2 ±0.1 by the addition of sodium hydroxide TS (about 175 mL), add water to volume, and mix. Dispense and sterilize. Store under refrigeration.For use, dilute the Stock Solution with water in the ratio of 1 to 800, and sterilize.MediaUnless otherwise indicated, the media should be sterilized by heating in an autoclave (see Steam Sterilization under Sterilization 〈1211〉), the exposure time depending on the volume to be sterilized.I. Fluid Casein Digest–Soy Lecithin–Polysorbate 20 MediumDissolve the pancreatic digest of casein and soy lecithin in 960 mL of water,heating in a water bath at 48to 50for about 30 minutes to effect solution. Add 40 mL of polysorbate 20. Mix, and dispense as desired.II. Soybean–Casein Digest Agar MediumpH after sterilization: 7.3 ± 0.2.III. Fluid Soybean–Casein Digest MediumIV. Mannitol–Salt Agar MediumMix, then heat with frequent agitation, and boil for 1 minute to effect solution. pH after sterilization: 7.4 ± 0.2.V. Baird–Parker Agar MediumHeat with frequent agitation, and boil for 1 minute. Sterilize, cool to between45and 50, and add 10 mL of sterile potassium tellurite solution (1 in 100) and 50 mL of egg-yolk emulsion. Mix intimately but gently, and pour into plates. (Prepare the egg-yolk emulsion by disinfecting the surface of whole shell eggs, aseptically cracking the eggs, and separating out intact yolks into a sterile graduated cylinder. Add sterile saline TS to obtain a 3 to 7 ratio of egg yolk to saline. Add to a sterile blender cup, and mix at high speed for 5 seconds.)pH after sterilization: 6.8 ± 0.2.VI. Vogel–Johnson Agar MediumBoil the solution of solids for 1 minute. Sterilize, cool to between 45and 50, and add 20 mL of sterile potassium tellurite solution (1 in 100).pH after sterilization: 7.2 ± 0.2.VII. Cetrimide Agar MediumDissolve all solid components in the water, and add the glycerin. Heat, with frequent agitation, and boil for 1 minute to effect solution.pH after sterilization: 7.2 ± 0.2.VIII. Pseudomonas Agar Medium for Detection of FluorescinDissolve the solid components in the water before adding the glycerin. Heat, with frequent agitation, and boil for 1 minute to effect solution.pH after sterilization: 7.2 ± 0.2.IX. Pseudomonas Agar Medium for Detection of PyocyaninDissolve the solid components in the water before adding the glycerin. Heat, with frequent agitation, and boil for 1 minute to effect solution.pH after sterilization: 7.2 ± 0.2.X. Fluid Lactose MediumCool as quickly as possible after sterilization.pH after sterilization: 6.9 ± 0.2.XI. Fluid Selenite–Cystine MediumFinal pH: 7.0 ± 0.2.Mix, and heat to effect solution. Heat in flowing steam for 15 minutes. Do not sterilize.XII. Fluid Tetrathionate MediumHeat the solution of solids to boiling. On the day of use, add a solution prepared by dissolving 5 g of potassium iodide and 6 g of iodine in 20 mL of water. Then add 10 mL of a solution of brilliant green (1 in 1000), and mix. Do not heat the medium after adding the brilliant green solution.XIII. Brilliant Green Agar MediumBoil the solution of solids for 1 minute. Sterilize just prior to use, melt the medium, pour into petri dishes, and allow to cool.pH after sterilization: 6.9 ± 0.2.XIV. Xylose–Lysine–Desoxycholate Agar MediumFinal pH: 7.4 ± 0.2.Heat the mixture of solids and water, with swirling, just to the boiling point. Do not overheat or sterilize. Transfer at once to a water bath maintained at about 50, and pour into plates as soon as the medium has cooled.XV. Bismuth Sulfite Agar MediumFinal pH: 7.6 ± 0.2.Heat the mixture of solids and water, with swirling, just to the boiling point. Do not overheat or sterilize. Transfer at once to a water bath maintained at about 50, and pour into plates as soon as the medium has cooled.XVI. Triple Sugar–Iron–Agar MediumpH after sterilization: 7.3 ± 0.2.XVII. MacConkey Agar MediumBoil the mixture of solids and water for 1 minute to effect solution.pH after sterilization: 7.1 ± 0.2.XVIII. Levine Eosin–Methylene Blue Agar MediumDissolve the pancreatic digest of gelatin, the dibasic potassium phosphate, and the agar in the water, with warming, and allow to cool. Just prior to use, liquefy the gelled agar solution, add the remaining ingredients, as solutions, in the following amounts, and mix: for each 100 mL of the liquefied agar solution—5 mL of lactose solution (1 in 5), 2 mL of the eosin Y solution (1 in 50), and 2 mL of methylene blue solution (1 in 300). The finished medium may not be clear.pH after sterilization: 7.1 ± 0.2.XIX. Sabouraud Dextrose Agar MediumMix, and boil to effect solution.pH after sterilization: 5.6 ± 0.2.XX. Potato Dextrose Agar MediumDissolve by heating, and sterilize.pH after sterilization: 5.6 ± 0.2.For use, just prior to pouring the plates, adjust the melted and cooled to 45 medium with sterile tartaric acid solution (1 in 10) to a pH of 3.5 ± 0.1. Do not reheat the pH 3.5 medium.SAMPLINGProvide separate 10-mL or 10-g specimens for each of the tests called for in the individual monograph.PROCEDUREPrepare the specimen to be tested by treatment that is appropriate to its physical characteristics and that does not alter the number and kind of microorganisms originally present, in order to obtain a solution or suspension of all or part of it in a form suitable for the test procedure(s) to be carried out.For a solid that dissolves to an appreciable extent but not completely, reduce the substance to a moderately fine powder, suspend it in the vehicle specified, and proceed as directed under Total Aerobic Microbial Count, and under Test for Staphylococcus aureus and Pseudomonas aeruginosa and Test for Salmonella species and Escherichia coli.For a fluid specimen that consists of a true solution, or a suspension in water or a hydroalcoholic vehicle containing less than 30 percent of alcohol, and for a solid that dissolves readily and practically completely in 90 mL of pH 7.2 Phosphate Buffer or the media specified, proceed as directed under Total Aerobic Microbial Count, and under Test for Staphylococcus aureus and Pseudomonas aeruginosa and Test for Salmonella species and Escherichia coli.For water-immiscible fluids, ointments, creams, and waxes, prepare a suspension with the aid of a minimal quantity of a suitable, sterile emulsifying agent (such as one of the polysorbates), using a mechanical blender andwarming to a temperature not exceeding 45, if necessary, and proceed with the suspension as directed under Total Aerobic Microbial Count, and under Test for Staphylococcus aureus and Pseudomonas aeruginosa and Test for Salmonella species and Escherichia coli.For a fluid specimen in aerosol form, chill the container in an alcohol-dry ice mixture for approximately 1 hour, cut open the container, allow it to reach room temperature, permit the propellant to escape, or warm to drive off the propellant if feasible, and transfer the quantity of test material required for the procedures specified in one of the two preceding paragraphs, as appropriate. Where 10.0 g or 10.0 mL of the specimen, whichever is applicable, cannot be obtained from 10 containers in aerosol form, transfer the entire contents from 10 chilled containers to the culture medium, permit the propellant to escape, and proceed with the test on the residues. If the results of the test areinconclusive or doubtful, repeat the test with a specimen from 20 more containers.Total Aerobic Microbial CountFor specimens that are sufficiently soluble or translucent to permit use of the Plate Method, use that method; otherwise, use the Multiple-Tube Method. With either method, first dissolve or suspend 10.0 g of the specimen if it is a solid, or 10 mL, accurately measured, if the specimen is a liquid, in pH 7.2 Phosphate Buffer, Fluid Soybean–Casein Digest Medium, or Fluid Casein Digest–Soy Lecithin-Polysorbate 20 Medium to make 100 mL. For viscous specimens that cannot be pipeted at this initial 1:10 dilution, dilute the specimen until a suspension is obtained, i.e., 1:50 or 1:100, etc., that can be pipeted. Perform the test for absence of inhibitory (antimicrobial) properties as described under Preparatory Testing before the determination of Total Aerobic Microbial Count. Add the specimen to the medium not more than 1 hour after preparing the appropriate dilutions for inoculation.PLATE METHODDilute further, if necessary, the fluid so that 1 mL will be expected to yield between 30 and 300 colonies. Pipet 1 mL of the final dilution onto each of two sterile petri dishes. Promptly add to each dish 15 to 20 mL of Soybean–Casein Digest Agar Medium that previously has been melted and cooled toapproximately 45. Cover the petri dishes, mix the sample with the agar by tilting or rotating the dishes, and allow the contents to solidify at room temperature. Invert the petri dishes, and incubate for 48 to 72 hours. Following incubation, examine the plates for growth, count the number of colonies, and express the average for the two plates in terms of the number of microorganisms per g or per mL of specimen. If no microbial colonies are recovered from the dishes representing the initial 1:10 dilution of the specimen, express the results as ―less than 10 microorganisms per g or per mL of specimen.‖MULTIPLE-TUBE METHODInto each of fourteen test tubes of similar size place 9.0 mL of sterile Fluid Soybean–Casein Digest Medium. Arrange twelve of the tubes in four sets of three tubes each. Put aside one set of three tubes to serve as the controls. Into each of three tubes of one set (―100‖) and into a fourth tube (A) pipet 1 mL of the solution or suspension of the specimen, and mix. From tube A, pipet 1 mL of its contents into the one remaining tube (B) not included in a set, and mix. These two tubes contain 100 mg (or 100 µL) and 10 mg (or 10 µL) of the specimen, respectively. Into each of the second set (―10‖) of three tubes pipet1 mL from tube A, and into each tube of the third set (―1‖) pipet 1 mL from tubeB. Discard the unused contents of tubes A and B. Close well, and incubate all of the tubes. Following the incubation period, examine the tubes for growth: the three control tubes remain clear and the observations in the tubes containing the specimen, when interpreted by reference to Table 1, indicate the most probable number of microorganisms per g or per mL of specimen.Table 1. Most Probable Total Count by Multiple-Tube MethodTest for Staphylococcus aureus and Pseudomonas aeruginosaTo the specimen add Fluid Soybean–Casein Digest Medium to make 100 mL, mix, and incubate. Examine the medium for growth, and if growth is present, use an inoculating loop to streak a portion of the medium on the surface of Vogel–Johnson Agar Medium (or Baird–Parker Agar Medium, or Mannitol–Salt Agar Medium) and of Cetrimide Agar Medium, each plated on petri dishes. Cover and invert the dishes, and incubate. If, upon examination, none of the plates contains colonies having the characteristics listed in Tables 2 and 3 for the media used, the test specimen meets the requirements for freedom from Staphylococcus aureus and Pseudomonas aeruginosa.Table 2. Morphologic Characteristics of Staphylococcus aureus on SelectiveAgar MediaTable 3. Morphologic Characteristics of Pseudomonas aeruginosa onSelective and Diagnostic Agar MediaCoagulase Test (for Staphylococcus aureus )— With the aid of an inoculating loop, transfer representative suspect colonies from the agar surfaces of the Vogel –Johnson Agar Medium (or Baird –Parker Agar Medium, or Mannitol –Salt Agar Medium) to individual tubes, each containing 0.5 mL of mammalian, preferably rabbit or horse, plasma with or without suitable additives. Incubate in a water bath at 37, examining the tubes at 3 hours and subsequently at suitable intervals up to 24 hours. Test positive and negative controlssimultaneously with the unknown specimens. If no coagulation in any degree is observed, the specimen meets the requirements of the test for absence of Staphylococcus aureus .Oxidase and Pigment Tests (for Pseudomonas aeruginosa )— With the aid of an inoculating loop, streak representative suspect colonies from the agarsurface of Cetrimide Agar Medium on the agar surfaces of Pseudomonas AgarMedium for Detection of Fluorescin and Pseudomonas Agar Medium for Detection of Pyocyanin contained in petri dishes. If numerous colonies are to be transferred, divide the surface of each plate into quadrants, each of which may be inoculated from a separate colony. Cover and invert the inoculatedmedia, and incubate at 35 ± 2for not less than three days. Examine the streaked surfaces under UV light. Examine the plates to determine whether colonies having the characteristics listed in Table 3 are present.Confirm any suspect colonial growth on one or more of the media as Pseudomonas aeruginosa by means of the oxidase test. Upon the colonial growth place or transfer colonies to strips or disks of filter paper that previously has been impregnated with N,N-dimethyl-p-phenylenediamine dihydrochloride: if there is no development of a pink color, changing to purple, the specimen meets the requirements of the test for the absence of Pseudomonas aeruginosa. The presence of Pseudomonas aeruginosa may be confirmed by other suitable cultural and biochemical tests, if necessary.Test for Salmonella species and Escherichia coliTo the specimen, contained in a suitable vessel, add a volume of Fluid Lactose Medium to make 100 mL, and incubate. Examine the medi um for growth, and if growth is present, mix by gently shaking. Pipet 1-mL portions into vessels containing, respectively, 10 mL of Fluid Selenite–Cystine Medium and Fluid Tetrathionate Medium, mix, and incubate for 12 to 24 hours. (Retain the remainder of the Fluid Lactose Medium.)Test for Salmonella Species— By means of an inoculating loop, streak portions from both the selenite-cystine and tetrathionate media on the surface of Brilliant Green Agar Medium, Xylose–Lysine–Desoxycholate Agar Medium, and Bismuth Sulfite Agar Medium contained in petri dishes. Cover and invert the dishes, and incubate. Upon examination, if none of the colonies conforms to the description given in Table 4, the specimen meets the requirements of the test for absence of the genus Salmonella.Table 4. Morphologic Characteristics of Salmonella Species on Selective AgarMediaIf colonies of Gram-negative rods matching the description in Table 4 are found, proceed with further identification by transferring representative suspect colonies individually, by means of an inoculating wire, to a butt-slant tube of Triple Sugar–Iron–Agar Medium by first streaking the surface of the slant and then stabbing the wire well beneath the surface. Incubate. If examination discloses no evidence of tubes having alkaline (red) slants and acid (yellow) butts (with or without concomitant blackening of the butt from hydrogen sulfide production), the specimen meets the requirements of the test for the absence of the genus Salmonella.*Test for Escherichia coli— By means of an inoculating loop, streak a portion from the remaining Fluid Lactose Medium on the surface of MacConkey Agar Medium. Cover and invert the dishes, and incubate. Upon examination, if none of the colonies conforms to the description given in Table 5 for this medium, the specimen meets the requirements of the test for absence of Escherichia coli.Table 5. Morphologic Characteristics of Escherichia coli on MacConkey AgarMediumIf colonies matching the description in Table 5 are found, proceed with further identification by transferring the suspect colonies individually, by means of an inoculating loop, to the surface of Levine Eosin–Methylene Blue Agar Medium, plated on petri dishes. If numerous colonies are to be transferred, divide the surface of each plate into quadrants, each of which may be seeded from a separate colony. Cover and invert the plates, and incubate. Upon examination, if none of the colonies exhibits both a characteristic metallic sheen under reflected light and a blue-black appearance under transmitted light, the specimen meets the requirements of the test for the absence of Escherichia coli. The presence of Escherichia coli may be confirmed by further suitable cultural and biochemical tests.Total Combined Molds and Yeasts CountProceed as for the Plate Method under Total Aerobic Microbial Count, except for using the same amount of Sabouraud Dextrose Agar Medium or Potato Dextrose Agar Medium, instead of Soybean Casein Digest Medium, andexcept for incubating the inverted petri dishes for 5 to 7 days at 20to 25.RetestFor the purpose of confirming a doubtful result by any of the procedures outlined in the foregoing tests following their application to a 10.0-g specimen, a retest on a 25-g specimen of the product may be conducted. Proceed as directed for Procedure, but make allowance for the larger specimen size.*Additional, confirmatory evidence may be obtained by use of procedures set fort h in Official Methods of Analysis of the AOAC, 12th ed. (1975), sections 46.013-46.026.。

相关文档
最新文档